Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
Journal article, Peer reviewed
MetadataShow full item record
Original versionBMJ Case Reports. 2020;13:e235194 10.1136/bcr-2020-235194
Aqueous misdirection syndrome is a rare, incompletely understood, sight-threatening eye condition that is difficult to diagnose and treat. We present a case of simultaneous bilateral aqueous misdirection following the administration of certolizumab in a 41-year-old women with rheumatoid arthritis and no known risk factors. To our knowledge, aqueous misdirection has not previously been associated with the use of tumour necrosis factor-alpha inhibitors.